7154 An International Expanded Access Program (EAP) of RAD001 (everolimus) in patients with metastatic renal cell carcinoma (mRCC) who fail, or become intolerant of a prior vascular endothelial growth factor receptor (VEGFr) therapy

✍ Scribed by Grünwald, V.; Rah, S.Y.; Miller, K.; Karakiewicz, P.I.; Machiels, J.P.; Hajdenberg, J.J.; Rini, B.I.; Rosamilia, M.; Resta, D.; Lee, S.H.

• Book ID: 123034441
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 49 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71487-9